{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:14:11Z","timestamp":1783149251594,"version":"3.54.6"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["101080189"],"award-info":[{"award-number":["101080189"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["899871"],"award-info":[{"award-number":["899871"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ejim.2024.01.002","type":"journal-article","created":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T13:46:10Z","timestamp":1706363170000},"page":"37-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-4815","authenticated-orcid":false,"given":"Giuseppe","family":"Boriani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9085-8390","authenticated-orcid":false,"given":"Luigi","family":"Gerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide A","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niccolo\u2019","family":"Bonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Vitolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1452-2478","authenticated-orcid":false,"given":"Marco","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3403-3364","authenticated-orcid":false,"given":"Jacopo F","family":"Imberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2024.01.002_bib0001","article-title":"Asymptomatic vs. symptomatic atrial fibrillation: clinical outcomes in heart failure patients","author":"Boriani","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.002_bib0002","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/euac062","article-title":"Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET\/EHRA consensus conference","volume":"25","author":"Schnabel","year":"2023","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.ejim.2024.01.002_bib0003","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1093\/europace\/euac038","article-title":"How to use digital devices to detect and manage arrhythmias: an EHRA practical guide","volume":"24","author":"Svennberg","year":"2022","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.ejim.2024.01.002_bib0004","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/17434440.2022.2070005","article-title":"Mobile health technology in atrial fibrillation","volume":"19","author":"Bonini","year":"2022","journal-title":"Expert Rev Med Devices"},{"issue":"8","key":"10.1016\/j.ejim.2024.01.002_bib0005","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad176","article-title":"The digital journey: 25 years of digital development in electrophysiology from an Europace perspective","volume":"25","author":"Svennberg","year":"2023","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.ejim.2024.01.002_bib0006","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2024.01.002_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2022.04.023","article-title":"Comparing atrial fibrillation guidelines: focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations","volume":"101","author":"Imberti","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2024.01.002_bib0008","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejim.2022.11.004","article-title":"Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: a report from the ESC-EHRA EORP-AF long-term general registry","volume":"107","author":"Ding","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.ejim.2024.01.002_bib0009","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u2018atrial fibrillation better care\u2019 pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.ejim.2024.01.002_bib0010","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/europace\/euaa274","article-title":"Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry","volume":"23","author":"Proietti","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2024.01.002_bib0011","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","author":"Joglar","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"10.1016\/j.ejim.2024.01.002_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10173979","article-title":"Comparing outcomes in asymptomatic and symptomatic atrial fibrillation: a systematic review and meta-analysis of 81,462 patients","volume":"10","author":"Sgreccia","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ejim.2024.01.002_bib0013","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/europace\/euac144","article-title":"Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper","volume":"25","author":"Kalarus","year":"2023","journal-title":"Europace"},{"issue":"2","key":"10.1016\/j.ejim.2024.01.002_bib0014","doi-asserted-by":"crossref","first-page":"oead031","DOI":"10.1093\/ehjopen\/oead031","article-title":"Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence","volume":"3","author":"Corica","year":"2023","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.ejim.2024.01.002_bib0015","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejim.2022.06.023","article-title":"Epidemiology of subclinical atrial fibrillation in patients with cardiac implantable electronic devices: a systematic review and meta-regression","volume":"103","author":"Proietti","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2024.01.002_bib0016","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ejim.2021.05.038","article-title":"Device-detected atrial high rate episodes and the risk of stroke\/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis","volume":"92","author":"Vitolo","year":"2021","journal-title":"Eur J Intern Med"},{"issue":"3","key":"10.1016\/j.ejim.2024.01.002_bib0017","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.hrthm.2017.11.007","article-title":"Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden","volume":"15","author":"Boriani","year":"2018","journal-title":"Heart Rhythm"},{"issue":"3","key":"10.1016\/j.ejim.2024.01.002_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/biology11030443","article-title":"Atrial high-rate episodes detected by cardiac implantable electronic devices: dynamic changes in episodes and predictors of incident atrial fibrillation","volume":"11","author":"Imberti","year":"2022","journal-title":"Biology"},{"issue":"12","key":"10.1016\/j.ejim.2024.01.002_bib0019","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrcardio.2017.94","article-title":"Management of atrial high-rate episodes detected by cardiac implanted electronic devices","volume":"14","author":"Freedman","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.ejim.2024.01.002_bib0020","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.ejim.2024.01.002_bib0021","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"Van Gelder","year":"2017","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ejim.2024.01.002_bib0022","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/eurheartj\/eht491","article-title":"Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)","volume":"35","author":"Boriani","year":"2014","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.ejim.2024.01.002_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022487","article-title":"Atrial high-rate episode duration thresholds and thromboembolic risk: a systematic review and meta-analysis","volume":"10","author":"Sagris","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"22","key":"10.1016\/j.ejim.2024.01.002_bib0024","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1161\/CIRCULATIONAHA.118.038988","article-title":"Practice variation in anticoagulation prescription and outcomes after device-detected atrial fibrillation","volume":"139","author":"Perino","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2024.01.002_bib0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijcard.2019.07.039","article-title":"Oral anticoagulation for subclinical atrial tachyarrhythmias detected by implantable cardiac devices: an international survey of the AF-SCREEN Group","volume":"296","author":"Boriani","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2024.01.002_bib0026","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vph.2016.03.006","article-title":"Atrial fibrillation burden and atrial fibrillation type: clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation","volume":"83","author":"Boriani","year":"2016","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.ejim.2024.01.002_bib0027","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejim.2022.11.015","article-title":"Natural history of \u2018silent\u2019 atrial fibrillation from subclinical to asymptomatic: state of the art and need for research","volume":"107","author":"Proietti","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"7","key":"10.1016\/j.ejim.2024.01.002_bib0028","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad166","article-title":"The influence of atrial high-rate episodes on stroke and cardiovascular death: an update","volume":"25","author":"Toennis","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2024.01.002_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2023.04.020","article-title":"Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022","volume":"114","author":"Boriani","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"9","key":"10.1016\/j.ejim.2024.01.002_bib0030","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad226","article-title":"Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal","volume":"25","author":"Lip","year":"2023","journal-title":"Europace."},{"key":"10.1016\/j.ejim.2024.01.002_bib0031","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","author":"Healey","year":"2023","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.ejim.2024.01.002_bib0032","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ejim.2024.01.002_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cvr\/cvab147","article-title":"Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes","volume":"117","author":"Boriani","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ejim.2024.01.002_bib0034","article-title":"Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA Trials","author":"McIntyre","year":"2023","journal-title":"Circulation"},{"issue":"7323","key":"10.1016\/j.ejim.2024.01.002_bib0035","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/bmj.323.7323.1218","article-title":"Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study","volume":"323","author":"Devereaux","year":"2001","journal-title":"BMJ"},{"issue":"4 Pt 1","key":"10.1016\/j.ejim.2024.01.002_bib0036","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0002-8703(98)70019-5","article-title":"Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke","volume":"136","author":"Samsa","year":"1998","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ejim.2024.01.002_bib0037","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jacc.2014.11.013","article-title":"Adding rigor to stroke risk prediction in atrial fibrillation","volume":"65","author":"Singer","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2024.01.002_bib0038","article-title":"Anticoagulation with edoxaban in patients with long Atrial High-Rate Episodes \u226524\u2005hours","author":"Becher","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2024.01.002_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2023.04.011","article-title":"Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices","volume":"115","author":"Boriani","year":"2023","journal-title":"Eur J Intern Med"},{"issue":"9","key":"10.1016\/j.ejim.2024.01.002_bib0040","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad233","article-title":"Remote monitoring of cardiac implantable electronic devices and disease management","volume":"25","author":"Varma","year":"2023","journal-title":"Europace"},{"issue":"12","key":"10.1016\/j.ejim.2024.01.002_bib0041","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/europace\/euac118","article-title":"Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe","volume":"24","author":"Boriani","year":"2022","journal-title":"Europace"},{"issue":"5","key":"10.1016\/j.ejim.2024.01.002_bib0042","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad123","article-title":"2023 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on practical management of the remote device clinic","volume":"25","author":"Ferrick","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2024.01.002_bib0043","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejim.2022.05.019","article-title":"The search for a gold standard to clinically diagnose and monitor atrial cardiomyopathy","volume":"101","author":"Boriani","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ejim.2024.01.002_bib0044","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejim.2022.03.007","article-title":"Atrial cardiomyopathy: pathophysiology and clinical implications","volume":"101","author":"Tufano","year":"2022","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.ejim.2024.01.002_bib0045","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2459\/JCM.0000000000001316","article-title":"Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications","volume":"23","author":"Boriani","year":"2022","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"7","key":"10.1016\/j.ejim.2024.01.002_bib0046","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/europace\/euac010","article-title":"Comparison of various late gadolinium enhancement magnetic resonance imaging methods with high-definition voltage and activation mapping for detection of atrial cardiomyopathy","volume":"24","author":"Eichenlaub","year":"2022","journal-title":"Europace"},{"key":"10.1016\/j.ejim.2024.01.002_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2023.10.023","article-title":"Atrial cardiomyopathy: an entity of emerging interest in the clinical setting","author":"Boriani","year":"2023","journal-title":"Eur J Intern Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620524000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T17:08:33Z","timestamp":1729098513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620524000025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":47,"alternative-id":["S0953620524000025"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2024.01.002","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2024.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.","name":"copyright","label":"Copyright"}]}}